longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

LABX

LABX
----

LongbridgeAI

Weekly Recap | Astera Labs +1.58%, a failed push above $310

Weekly Review
Aug 29, 2026 at 05:14 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Astera Labs rose 1.58% this week to close at $289.47, outpacing the S&P 500 by roughly 1.09 percentage points. The week’s range was wide at 16.13%, with a pattern of early dip and late reversal. Monday (Aug 24) opened at $271.69, fell to an intraday low of $266.31, then recovered most of the loss to close at $277.53. Tuesday and Wednesday pushed higher, with Wednesday ending at $290.30. Thursday accelerated to a high of $310.14 before closing at $304.09. Friday hit $301.

The Week

Astera Labs rose 1.58% this week to close at $289.47, outpacing the S&P 500 by roughly 1.09 percentage points. The week’s range was wide at 16.13%, with a pattern of early dip and late reversal. Monday (Aug 24) opened at $271.69, fell to an intraday low of $266.31, then recovered most of the loss to close at $277.53. Tuesday and Wednesday pushed higher, with Wednesday ending at $290.30. Thursday accelerated to a high of $310.14 before closing at $304.09. Friday hit $301.04 early before pulling back to settle at $289.47. Volume was on the light side, with average daily turnover about 46% below the recent median.

Key Events

The week revolved around one main thread: an analyst removed Astera Labs from a top picks list, reigniting valuation concerns. Pre-market and overnight sessions on Monday were already down about 3%, and the stock fell as much as 6% during regular trading before paring losses. Media coverage on Monday and Tuesday framed the move around valuation risk. From Wednesday to Thursday the stock regained strength, rising about 2.7% on Thursday, with overnight and pre-market gains around 3.8%. Light Street Capital Management disclosed a new position on Thursday. There were no company earnings or major partnership announcements; the action came mainly from price swings and a single institutional position change.

Analyst Ratings

Of the 26 firms covering the stock, 12 rate it buy, 7 rate it overweight, and 7 rate it hold, with no underweight or sell ratings. The consensus rating is buy, and the consensus target price is $389.95, about 34.7% above the latest close. Target prices range from $190 to $500, showing wide dispersion. Among 77 semiconductor companies in the industry coverage, Astera Labs ranks 14th by rating.

The Week Ahead

No company earnings are scheduled next week. The focus shifts to US macro data. Monday (Aug 31) brings the Dallas Fed manufacturing business activity index; Tuesday (Sep 1) includes the S&P Global manufacturing PMI final, ISM manufacturing PMI, and JOLTS job openings; Wednesday (Sep 2) brings ADP private payrolls, factory orders, and EIA crude inventories. These prints will shape the repricing of semiconductor demand and the rate path, and serve as external signals on whether this week’s valuation concern carries over.

In Short

The week left a clear tension. The rating backdrop is favourable: 19 of 26 covering firms rate the stock buy or overweight, and the consensus target sits about 34.7% above spot. But valuation pressure is equally visible, with P/E around 135.9x and P/B around 29.1x, and the removal from a top picks list left the stock unable to hold above $310. The latest session’s fund flow showed small and medium orders as net buyers while large orders were net sellers. What matters next is how macro data and rate expectations evolve, and whether the current valuation can be absorbed by fresh demand signals.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Login to unlock2,536characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Astera Labs

Astera Labs

USALAB

+9.06%

ALAB 2X Long ETF

ALAB 2X Long ETF

USLABX